Harjai, K. J., Grines, C. L., Stone, G. W., Lansky, A. J., Aymong, E., Fahy, M., … Brodie, B. R. (2003). Does the use of heparin after primary angioplasty for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa antagonists alleviate recurrent cardiac ischemia? Insights from the CADILLAC study. In AMERICAN JOURNAL OF CARDIOLOGY (Vol. 92, pp. 42L-42L). WASHINGTON, D.C.: EXCERPTA MEDICA INC.

Harjai, K. J., C. L. Grines, G. W. Stone, A. J. Lansky, E. Aymong, M. Fahy, D. A. Cox, et al. “Does the use of heparin after primary angioplasty for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa antagonists alleviate recurrent cardiac ischemia? Insights from the CADILLAC study.” In AMERICAN JOURNAL OF CARDIOLOGY, 92:42L-42L. EXCERPTA MEDICA INC, 2003.

Harjai KJ, Grines CL, Stone GW, Lansky AJ, Aymong E, Fahy M, et al. Does the use of heparin after primary angioplasty for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa antagonists alleviate recurrent cardiac ischemia? Insights from the CADILLAC study. In: AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 2003. p. 42L-42L.

Harjai, K. J., et al. “Does the use of heparin after primary angioplasty for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa antagonists alleviate recurrent cardiac ischemia? Insights from the CADILLAC study.” AMERICAN JOURNAL OF CARDIOLOGY, vol. 92, no. 6A, EXCERPTA MEDICA INC, 2003, pp. 42L-42L.

Harjai KJ, Grines CL, Stone GW, Lansky AJ, Aymong E, Fahy M, Cox DA, Garcia E, Tcheng JE, Griffins JJ, Guagliumi G, Stuckey T, Turco M, Rutherford BD, Carroll JD, Brodie BR. Does the use of heparin after primary angioplasty for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa antagonists alleviate recurrent cardiac ischemia? Insights from the CADILLAC study. AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 2003. p. 42L-42L.